Shionogi Licenses Pirespa To South Korea's Ildong
This article was originally published in PharmAsia News
Executive Summary
Japan's Shionogi has out-licensed rights to Pirespa (pirfenidone) for idiopathic pulmonary fibrosis to South Korea's Ildong Pharmaceutical.